Evidence map›Paper›PMID 35619972›Full record

ArticleDelaware journal of public health2021

Molecular Genetic Testing for Kidney Disorders During the COVID-19 Pandemic.

Susan M Kirwin, Katherine M Robbins, Kathleen M B Vinette, Lee Hirata, Karen W Gripp, Vicky L Funanage

Open access · bronzeAbstract read
In one paragraph

Article in Delaware journal of public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Susan M KirwinNemours Children's Health, Molecular Diagnostics Laboratory.
Katherine M RobbinsNemours Children's Health, Molecular Diagnostics Laboratory.
Kathleen M B VinetteNemours Children's Health, Molecular Diagnostics Laboratory.
Lee HirataNemours Children's Health, Molecular Diagnostics Laboratory.
Karen W GrippNemours Children's Health, Molecular Diagnostics Laboratory.
Vicky L FunanageNemours Children's Health, Molecular Diagnostics Laboratory.
Nemours Children's Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) has major morbidity and mortality for children and adults. While in adults CKD often is associated with diabetic complications, genetic variants can be the underlying cause in both populations. Beginning in 2016 with the emergence of more affordable next-generation sequencing (NGS) technologies, the Molecular Diagnostics Lab at Nemours Children's Hospital-Delaware developed the first clinically actionable pediatric NGS kidney panel comprised of 46 genes including

Identifiers

PMID35619972
PMCPMC9124563
OpenAlexW4200281089

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.